company-logo

IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.

IR-Med Dividend Announcement

IR-Med does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on IR-Med dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

IR-Med Dividend History

IR-Med Dividend Yield

IR-Med current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing IR-Med stock? Use our calculator to estimate your expected dividend yield:

IR-Med Financial Ratios

P/E ratio-17.30
PEG ratio0.67
P/B ratio165.54
ROE-749.30%
Payout ratio0.00%
Current ratio2.15
Quick ratio2.15
Cash Ratio2.05

IR-Med Dividend FAQ

Does IR-Med stock pay dividends?
IR-Med does not currently pay dividends to its shareholders.
Has IR-Med ever paid a dividend?
No, IR-Med has no a history of paying dividends to its shareholders. IR-Med is not known for its dividend payments.
Why doesn't IR-Med pay dividends?
There are several potential reasons why IR-Med would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will IR-Med ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While IR-Med has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is IR-Med a dividend aristocrat?
IR-Med is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is IR-Med a dividend king?
IR-Med is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is IR-Med a dividend stock?
No, IR-Med is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy IR-Med stocks?
To buy IR-Med you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy IR-Med stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.